Position in ZTS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$31,651,814
-$77,612,880 QoQ
Shares Held
440,465
-52.3% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#123
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $338,809,559 across 34 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
6,276,154 | $58,556,516 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,702,176 | $57,669,722 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
262,192 | $44,189,839 | |
| 4 | VTRS |
Viatris Inc
|
2,354,974 | $37,396,987 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
440,465 | $31,651,814 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,598,174 | $25,618,729 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
934,265 | $22,992,261 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
35,362 | $19,160,192 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,651,814 | 440,465 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $109,264,694 | 924,327 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $157,356,908 | 1,250,651 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $271,818,371 | 1,857,698 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $341,412,289 | 2,189,242 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $357,611,732 | 2,171,951 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $347,296,863 | 2,131,571 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $442,472,006 | 2,264,674 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $390,197,474 | 2,250,793 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $345,492,978 | 2,041,800 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $311,837,297 | 1,579,963 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $271,764,415 | 1,562,044 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $199,570,724 | 1,158,880 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $197,174,643 | 1,184,659 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $176,852,143 | 1,206,770 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $173,952,770 | 1,173,058 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $193,233,237 | 1,124,168 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $274,381,665 | 1,454,911 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $361,881,116 | 1,482,937 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $277,772,405 | 1,430,784 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $268,668,875 | 1,441,666 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $221,359,714 | 1,405,637 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $213,718,259 | 1,291,349 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $203,283,553 | 1,229,265 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $164,246,414 | 1,198,529 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $128,185,358 | 1,089,178 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||